US DMFs Filed
USA (Orange Book)
PharmaCompass offers a list of Fluticasone Propionate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fluticasone Propionate manufacturer or Fluticasone Propionate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fluticasone Propionate manufacturer or Fluticasone Propionate supplier.
PharmaCompass also assists you with knowing the Fluticasone Propionate API Price utilized in the formulation of products. Fluticasone Propionate API Price is not always fixed or binding as the Fluticasone Propionate Price is obtained through a variety of data sources. The Fluticasone Propionate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fluticasone Propionate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fluticasone Propionate, including repackagers and relabelers. The FDA regulates Fluticasone Propionate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fluticasone Propionate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
CLICK HERE to find a list of Fluticasone Propionate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fluticasone Propionate supplier is an individual or a company that provides Fluticasone Propionate active pharmaceutical ingredient (API) or Fluticasone Propionate finished formulations upon request. The Fluticasone Propionate suppliers may include Fluticasone Propionate API manufacturers, exporters, distributors and traders.
CLICK HERE to find a list of Fluticasone Propionate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fluticasone Propionate DMF (Drug Master File) is a document detailing the whole manufacturing process of Fluticasone Propionate active pharmaceutical ingredient (API) in detail. Different forms of Fluticasone Propionate DMFs exist exist since differing nations have different regulations, such as Fluticasone Propionate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fluticasone Propionate DMF submitted to regulatory agencies in the US is known as a USDMF. Fluticasone Propionate USDMF includes data on Fluticasone Propionate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fluticasone Propionate USDMF is kept confidential to protect the manufacturer’s intellectual property.
CLICK HERE to find a list of Fluticasone Propionate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fluticasone Propionate Drug Master File in Japan (Fluticasone Propionate JDMF) empowers Fluticasone Propionate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fluticasone Propionate JDMF during the approval evaluation for pharmaceutical products. At the time of Fluticasone Propionate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
CLICK HERE to find a list of Fluticasone Propionate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fluticasone Propionate Drug Master File in Korea (Fluticasone Propionate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fluticasone Propionate. The MFDS reviews the Fluticasone Propionate KDMF as part of the drug registration process and uses the information provided in the Fluticasone Propionate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fluticasone Propionate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fluticasone Propionate API can apply through the Korea Drug Master File (KDMF).
CLICK HERE to find a list of Fluticasone Propionate suppliers with KDMF on PharmaCompass.
A Fluticasone Propionate CEP of the European Pharmacopoeia monograph is often referred to as a Fluticasone Propionate Certificate of Suitability (COS). The purpose of a Fluticasone Propionate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fluticasone Propionate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fluticasone Propionate to their clients by showing that a Fluticasone Propionate CEP has been issued for it. The manufacturer submits a Fluticasone Propionate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fluticasone Propionate CEP holder for the record. Additionally, the data presented in the Fluticasone Propionate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fluticasone Propionate DMF.
A Fluticasone Propionate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fluticasone Propionate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
CLICK HERE to find a list of Fluticasone Propionate suppliers with CEP (COS) on PharmaCompass.
A Fluticasone Propionate written confirmation (Fluticasone Propionate WC) is an official document issued by a regulatory agency to a Fluticasone Propionate manufacturer, verifying that the manufacturing facility of a Fluticasone Propionate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Fluticasone Propionate APIs or Fluticasone Propionate finished pharmaceutical products to another nation, regulatory agencies frequently require a Fluticasone Propionate WC (written confirmation) as part of the regulatory process.
CLICK HERE to find a list of Fluticasone Propionate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fluticasone Propionate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fluticasone Propionate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fluticasone Propionate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fluticasone Propionate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fluticasone Propionate NDC to their finished compounded human drug products, they may choose to do so.
CLICK HERE to find a list of Fluticasone Propionate suppliers with NDC on PharmaCompass.
Fluticasone Propionate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fluticasone Propionate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fluticasone Propionate GMP manufacturer or Fluticasone Propionate GMP API supplier for your needs.
A Fluticasone Propionate CoA (Certificate of Analysis) is a formal document that attests to Fluticasone Propionate's compliance with Fluticasone Propionate specifications and serves as a tool for batch-level quality control.
Fluticasone Propionate CoA mostly includes findings from lab analyses of a specific batch. For each Fluticasone Propionate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fluticasone Propionate may be tested according to a variety of international standards, such as European Pharmacopoeia (Fluticasone Propionate EP), Fluticasone Propionate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fluticasone Propionate USP).